U.S. Capital Wealth Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,691
Closed -$138K 1020
2025
Q4
$138K Buy
+11,691
New +$150K ﹤0.01% 954
2025
Q3
Sell
-10,188
Closed -$117K 944
2025
Q2
$117K Buy
+10,188
New +$115K ﹤0.01% 866

Other funds holding CC

U.S. Capital Wealth Advisors's CC Position: Q1 2026 in Review

U.S. Capital Wealth Advisors sold out of Chemours (CC) in Q1 2026, closing a stake of 11,691 shares — an estimated $138K sold.

U.S. Capital Wealth Advisors first reported a position in CC in Q2 2025 and held it in 2 quarters. The position peaked at $138K in Q4 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • U.S. Capital Wealth Advisors reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 11,691 Chemours shares in Q1 2026, an estimated $138K.
  • U.S. Capital Wealth Advisors first reported a position in Chemours in Q2 2025 and held it in 2 quarters.
  • U.S. Capital Wealth Advisors's Chemours position peaked at $138K in Q4 2025.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.